ZYME ▲ +1.9% - Zymeworks Inc.
$ZYME - Zymeworks Enters into an Exclusive Global License and Collaboration Agreement with Roche for ZW209, a Trispecific T cell Engager Targeting DLL3
23-OCT-2026 06:00 AM ET
Share this post
More filings for $ZYME
ZYME ▼ -0.2% - Zymeworks Inc.Oct 15, 2026ZYME ▼ -1.1% - Zymeworks Inc.Sep 28, 2026ZYME ▼ -0.3% - Zymeworks Inc.Sep 23, 2026
View full $ZYME filing history →💬 Comments
Loading comments…
Leave a comment